Sclerotherapy Market Outlook 2025 – Growth Roadmap and Therapeutic Innovation Insights

 Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics.

What is the anticipated market size of the sclerotherapy industry over the next few years?
The sclerotherapy market size has grown strongly in recent years. It will grow from $1.14 billion in 2024 to $1.22 billion in 2025 at a compound annual growth rate (CAGR) of 6.6%. The growth in the historic period can be attributed to rising prevalence of varicose veins, increasing aging population, growing demand for minimally invasive procedures, improved healthcare infrastructure, greater awareness of aesthetic treatments, and expanding insurance coverage for vein-related conditions.

The sclerotherapy market size is expected to see strong growth in the next few years. It will grow to $1.56 billion in 2029 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to increasing adoption of minimally invasive procedures, rising prevalence of chronic venous disorders, growing awareness about cosmetic vein treatments, expanding access to specialized vein clinics, increasing healthcare expenditure in emerging markets, and supportive regulatory initiatives promoting outpatient treatments. Major trends in the forecast period include advancements in foam-based formulations, integration of ultrasound-guided techniques, adoption of minimally invasive procedures, development of personalized treatment plans, use of AI for diagnostic precision, enhanced post-procedure recovery protocols, and expansion of outpatient vein clinics.

Download Your Free Sample PDF:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24394&type=smp

What emerging drivers are expected to shape the future of the sclerotherapy market?
The rising prevalence of varicose veins and spider veins is expected to propel the growth of the sclerotherapy market going forward. Varicose veins and spider veins refer to enlarged, twisted, or damaged veins often visible under the skin caused by poor blood flow, in the legs. The rise of prevalence of varicose veins and spider veins is due to the people spending more time sitting or standing for long periods, often linked to modern work habits. Sclerotherapy helps the prevalence of varicose veins and spider veins by allowing targeted injection of a solution that seals off damaged veins, improving blood flow and appearance. For instance, in January 2024, according to the National Center for Biotechnology Information, a US-Based health information organization, in Brazil, 47.6% of the population had varicose veins (VVs), with a higher prevalence among non-pregnant women at 50.9%, compared to 37.9% in men. Therefore, the rising prevalence of varicose veins and spider veins is going to drive the growth of sclerotherapy market.

Increasing Healthcare Expenditure Driving Market Growth Through Enhanced Access To Advanced Treatments

The rise in healthcare expenditure is expected to propel the growth of sclerotherapy market going forward. Healthcare expenditure is the overall spending on medical services, treatments, and health-related resources within a country or system. Rising healthcare expenditures are largely driven by the increasing costs of advanced medical technologies, which, while improving diagnosis and treatment, require significant investment in development, equipment, and specialized personnel. Healthcare expenditure supports sclerotherapy by funding access to specialized treatments, medical staff, and advanced equipment. For instance, in May 2024, according to the Office for National Statistics, a UK-based government department, reported that in 2024, the UK's healthcare expenditure reached approximately $421.32 billion (£317 billion), reflecting a 6.5% increase compared to 2023. Therefore, the rise in healthcare expenditure is going to drive the growth of sclerotherapy market.

What emerging segments are shaping the future landscape of the sclerotherapy industry?
The sclerotherapy market covered in this report is segmented –

1) By Type: Liquid Sclerotherapy, Foam Sclerotherapy, Ultrasound-Guided Sclerotherapy
2) By Agents: Detergents, Chemical Irritants, Osmotic Agents
3) By Application: Varicose Veins, Spider Veins, Hemorrhoids
4) By End-User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Other End-Users

Subsegments:
1) By Liquid Sclerotherapy: Polidocanol-based, Sodium Tetradecyl Sulfate (STS)-based, Hypertonic Saline-based
2) By Foam Sclerotherapy: Polidocanol Foam, STS Foam, Air-based Foam
3) By Ultrasound-Guided Sclerotherapy: Foam-guided, Liquid-guided, Combination Therapies

View The Full Market Report:
https://www.thebusinessresearchcompany.com/report/sclerotherapy-global-market-report

What are the key trends shaping the sclerotherapy market in the forecast period?
Major companies operating in the sclerotherapy market are focusing on strategic partnership, to enhance their research capabilities, expand product offerings, and strengthen their market presence through shared expertise and global distribution networks. Advanced minimally invasive treatments for varicose veins refer to modern procedures such as sclerotherapy, laser therapy, and radiofrequency ablation that effectively close or remove damaged veins with minimal pain, quick recovery, and reduced risk of complications. For instance, in February 2025, Aakash Healthcare, an India-Based specialty hospital, partnered with Medtronic plc, a US-based healthcare company launched specialized vein clinic, a clinic which offers advanced, minimally invasive treatments for varicose veins and other vein-related conditions, ensuring faster recovery and long-term health benefits for patients. Additionally, it also offers enhanced personalized treatment plans, and post-treatment care, ensuring a comprehensive approach to vein health and overall well-being.

How are key players in the sclerotherapy market strengthening their market position?
Major companies operating in the sclerotherapy market are Bayer AG, Sanofi S.A., Thermo Fisher Scientific Inc., Abbott Laboratories, Novartis AG, Medtronic plc, Boston Scientific Corporation, Olympus Corporation, Smith & Nephew plc, Teleflex Incorporated, Cook Medical, Merz Pharma GmbH & Co. KGaA, AngioDynamics Inc., Bioniche Pharma Group Ltd, Omega Pharmaceuticals Pvt. Ltd., Endo-Flex, Kreussler, Vascular Solutions, Inc., LGM Pharma, BTG International Ltd.

Which geographic areas are contributing significantly to the growth of the sclerotherapy sector?
North America was the largest region in the sclerotherapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sclerotherapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

How Can Companies Use The Sclerotherapy Market Report to Drive Business Results?
This report provides actionable insights tailored for business use—not academic analysis. Companies can leverage the data to:
• Time market entry or expansion using growth forecasts and CAGR trends.
• Develop competitive products by tracking key technology shifts and user preferences.
• Tailor regional strategies with in-depth geographic data and local market dynamics.
• Benchmark and plan partnerships using competitive landscape insights.

Purchase The Report And Get A Swift Delivery:
https://www.thebusinessresearchcompany.com/customise?id=24394&type=smp

Need Customized Data On Sclerotherapy Market?
For companies needing more tailored intelligence, The Business Research Company offers customized consulting and data services. Whether you're entering new regions, launching innovative products, or assessing M&A opportunities, our experts can develop actionable insights specific to your business objectives.

Request Customized Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24394&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.

Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

Contact Us:

The Business Research Company

https://thebusinessresearchcompany.com/

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: info@tbrc.info

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company